These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 15055301

  • 1. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
    French JE.
    IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
    [Abstract] [Full Text] [Related]

  • 2. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW, Blyth K, Cameron ER, Neil JC.
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [Abstract] [Full Text] [Related]

  • 3. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J, Storer RD, Donehower LA.
    Toxicol Pathol; 2001 Oct; 29 Suppl():24-9. PubMed ID: 11695559
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency.
    Lynch CJ, Milner J.
    Oncogene; 2006 Jun 08; 25(24):3463-70. PubMed ID: 16449974
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic pathways of two types of gastric cancer.
    Tahara E.
    IARC Sci Publ; 2004 Jun 08; (157):327-49. PubMed ID: 15055305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
    French JE, Lacks GD, Trempus C, Dunnick JK, Foley J, Mahler J, Tice RR, Tennant RW.
    Carcinogenesis; 2001 Jan 08; 22(1):99-106. PubMed ID: 11159747
    [Abstract] [Full Text] [Related]

  • 11. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
    Honma M.
    Environ Mol Mutagen; 2005 Jan 08; 45(2-3):162-76. PubMed ID: 15688360
    [Abstract] [Full Text] [Related]

  • 12. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
    Biggs PJ, Vogel H, Sage M, Martin LA, Donehower LA, Bradley A.
    Oncogene; 2003 May 22; 22(21):3288-96. PubMed ID: 12761499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo.
    Vrieling H, Wijnhoven S, van Sloun P, Kool H, Giphart-Gassler M, van Zeeland A.
    Environ Mol Mutagen; 1999 May 22; 34(2-3):84-9. PubMed ID: 10529730
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.